Efficacies of artemether–lumefantrine, artesunate–amodiaquine, dihydroartemisinin–piperaquine, and artesunate–pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial
Authors:
Top Cited Papers
- 20 August 2025
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 26 (1) , 67-78
Abstract
No abstract availableKeywords
Funding Information
- Foundation for the National Institutes of Health
- United States Agency for International Development
- President's Malaria Initiative
This publication has 26 references indexed in Scilit:
- Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in UgandaThe Journal of Infectious Diseases, 2024
- Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in AfricaNature Reviews Microbiology, 2024
- Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and LumefantrineClinical Infectious Diseases, 2023
- Evolution of Partial Resistance to Artemisinins in Malaria Parasites in UgandaNew England Journal of Medicine, 2023
- Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern UgandaNature Communications, 2022
- WHO antimalarial trial guidelines: good science, bad news?Trends in Parasitology, 2022
- Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic studyThe Lancet Microbe, 2021
- Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across UgandaThe Journal of Infectious Diseases, 2021
- Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort studyThe Lancet Infectious Diseases, 2016
- A molecular marker of artemisinin-resistant Plasmodium falciparum malariaNature, 2013